Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05063786 |
|---|---|
| Brief Title: | Trastuzumab + Alpelisib +/- Fulvestrant vs Trastuzumab + CT in Patients With PIK3CA Mutated Previously Treated HER2+ Advanced BrEasT Cancer (ALPHABET) (ALPHABET) |
| First Submitted : | July 21, 2021 |
| First Submitted that Met QC Criteria : | September 21, 2021 |
| First Posted : | October 1, 2021 |
| Last Update Submitted that Met QC Criteria : | April 9, 2024 |
| Last Update Posted : | April 10, 2024 |